Stocktoria
AbCellera Biologics Inc. ABCL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-12-11
Chart by TradingView
4/9
Piotroski F — financial health
4.67
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $75.1M | $28.8M | $38.0M | $485.4M | $375.2M |
| Operating income | -$217.1M | -$314.8M | -$237.2M | $216.5M | $204.4M |
| Net income | -$146.4M | -$162.9M | -$146.4M | $158.5M | $153.5M |
| Operating cash flow | -$131.3M | -$108.6M | -$43.9M | $277.4M | $244.6M |
| Free cash flow | -$174.1M | -$187.0M | -$120.8M | $206.7M | $186.1M |
| Total assets | $1.4B | $1.4B | $1.5B | $1.5B | $1.3B |
| Total liabilities | $390.0M | $304.5M | $335.8M | $307.6M | $292.8M |
| Shareholders' equity | $966.9M | $1.1B | $1.2B | $1.2B | $1.0B |
| Ratios | |||||
| Operating margin | -289.0% | -1091.7% | -623.8% | 44.6% | 54.5% |
| Net margin | -194.9% | -564.8% | -385.0% | 32.7% | 40.9% |
| FCF margin | -231.7% | -648.4% | -317.7% | 42.6% | 49.6% |
| Return on assets | -10.8% | -12.0% | -9.8% | 10.3% | 11.6% |
| Return on equity | -15.1% | -15.4% | -12.7% | 12.9% | 15.0% |
| Current ratio | 11.32 | 9.81 | 7.33 | 8.67 | 7.70 |
| Revenue growth | 160.6% | -24.2% | -92.2% | 29.4% | 60.9% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,510,629 | $5.3M |
| Point72 Asset Management, L.P. | 1,149,325 | $4.0M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.67 (safe)
- Working capital / assets 0.489
- Retained earnings / assets -0.022
- EBIT / assets -0.16
- Equity / liabilities 2.479
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001703057 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.